Psyence Biomedical Statistics
Total Valuation
PBM has a market cap or net worth of $2.02 million. The enterprise value is $1.39 million.
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025, before market open.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PBM has 4.43 million shares outstanding. The number of shares has increased by 239.30% in one year.
| Current Share Class | 4.43M |
| Shares Outstanding | 4.43M |
| Shares Change (YoY) | +239.30% |
| Shares Change (QoQ) | +19.96% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 10.71% |
| Float | 3.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -1.61 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.64
| Current Ratio | 0.64 |
| Quick Ratio | 0.59 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -110.20 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -137.78% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 256.66% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.18% in the last 52 weeks. The beta is -0.13, so PBM's price volatility has been lower than the market average.
| Beta (5Y) | -0.13 |
| 52-Week Price Change | -99.18% |
| 50-Day Moving Average | 0.81 |
| 200-Day Moving Average | 10.19 |
| Relative Strength Index (RSI) | 34.14 |
| Average Volume (20 Days) | 102,148 |
Short Selling Information
The latest short interest is 184,061, so 4.16% of the outstanding shares have been sold short.
| Short Interest | 184,061 |
| Short Previous Month | 194,421 |
| Short % of Shares Out | 4.16% |
| Short % of Float | 5.56% |
| Short Ratio (days to cover) | 1.41 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.22M |
| Pretax Income | -37.27M |
| Net Income | -46.59M |
| EBITDA | n/a |
| EBIT | -3.22M |
| Earnings Per Share (EPS) | -$76.91 |
Full Income StatementBalance Sheet
The company has $1.93 million in cash and $1.30 million in debt, giving a net cash position of $631,374 or $0.14 per share.
| Cash & Cash Equivalents | 1.93M |
| Total Debt | 1.30M |
| Net Cash | 631,374 |
| Net Cash Per Share | $0.14 |
| Equity (Book Value) | -1.26M |
| Book Value Per Share | -2.07 |
| Working Capital | -1.27M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.87 million and capital expenditures -$12,155, giving a free cash flow of -$2.89 million.
| Operating Cash Flow | -2.87M |
| Capital Expenditures | -12,155 |
| Free Cash Flow | -2.89M |
| FCF Per Share | -$0.65 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |